Report #2863375

Received Oct 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 78 yrs
State: GA
Recovered: Unknown
Vaccinated: Sep 5, 2025
Onset: Sep 5, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	H97H2	—

Symptoms (1)

Extra dose administered

Symptom narrative

3rd dose was given in 05-Sep-2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 78-year-old male patient who received Herpes zoster (Shingrix) (batch number H97H2) for prophylaxis. Previously administered products included Shingrix (patient received 1 dose of Shingrix in 2021) and Shingrix (patient received 2 dose of Shingrix in 2021). On 05-SEP-2025, the patient received the 3rd dose of Shingrix. On 05-SEP-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: 3rd dose was given in 05-Sep-2025). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date: 26-SEP-2025 The Vaccine Administration Facility was the same as Primary Reporter.